The antigenic similarities and differences between various actins were explored by use of antisera against purified bovine cardiac actin and chicken embryo brain actin. In double-antibody coprecipitation tests, purified iodinated actins from bovine cardiac muscle, rabbit skeletal muscle, chicken embryo brain, and bovine brain all bound to antiserum against chicken embryo brain actin. This result demonstrates the-presence of shared antigenic determinants among these actins. Cardiac actin antiserum, on the other hand, bound cardiac and skeletal actin, but failed to bind significantly either brain actin. In radioimmunoassay, all four unlabeled actins were capable of some degree of inhibition of binding of 125I-labeled chicken-embryo brain actin to homologous antiserum. The results confirm the existence of shared or similar antigenic determinants, but also show that the molecules are not antigenically identical. In the cardiac actin radioimmunoassay, unlabeled cardiac and skeletal muscle actins inhibited the binding of 125I-labeled cardiac actin to homologous antiserum, but neither brain actin inhibited the binding. Thus, the muscle actins possess at least one antigenic determinant not expressed by the brain actins, in addition to the shared determinants. Furthermore, cardiac actin and skeletal actin generated different inhibition curves in the cardiac actin-radioimmunoassay, demonstrating that, although antigenically related, they are not identical. Correlations with existing sequence data imply that substitutions in only a few residues alter the antigenic properties of actin.
Actin is a ubiquitous molecule in eukaryotic cells that is involved in various cellular and developmental activities, ranging from cytoplasmic streaming (1) and protein mobility in plasma membranes (2) to cytokinesis (3) and morphogenetic movements of cells (4, 5) . Actins purified from various cell and tissue types are similar to actin from skeletal muscle in molecular size, peptide maps, amino acid composition and sequence, and the ability to self-assemble into filaments, to bind heavy meromyosin, to activate myosin ATPase, to inhibit DNase I activity, and to interact with various actin-binding proteins (see reviews in refs. [6] [7] [8] [9] . In addition, studies with antibodies against various actins have revealed immunological similarities by immunofluorescence and immunodiffusion analyses (10) (11) (12) (13) . However, a variety of studies have revealed that, although highly similar, various actins are not identical. Differences have been reported in polymerization properties (14) , polyacrylamide gel electrophoresis properties (15) , behavior in electrofocusing gels (16) (17) (18) , and primary structure by amino acid sequence analyses (19) (20) (21) . Ultimate understanding of the in vivo properties and regulation of various actins requires a better understanding of the effects of various amino acid substitutions on the properties of the native molecule. Recent success in producing actin crystals (22) offers promise of eventual solution of actin structure and comparative studies at that level. In lieu of crystallo-
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisenent" in accordance with 18 U. S. C. §1734 (23) . Chicken embryo and bovine brain actins were purified by the methods of Pardee (24) . Purification of both muscle and brain actins involved two cycles of polymerization, the major difference being that extracts from brain acetone powders were first fractionated on Sephadex G-150 before the actin-rich peak was polymerized. Actins from bovine cardiac muscle and chicken embryo brain were used to immunize rabbits. Purified F-actin was treated with glutaraldehyde (2%) and dialyzed overnight against saline. Rabbits were given primary subcutaneous injections of 2 mg of antigen in complete Freund's adjuvant, followed by 2-mg booster injections (in incomplete Freund's adjuvant) at 2 weeks and at 4 weeks. Thereafter, booster injections were given at 3-month intervals. Antisera were collected at weekly intervals and pooled for each rabbit for these experiments.
Purified G-actins were labeled with 125I by two techniques. The first was through the iodinated imidoester, methyl-3,5-diiodo-p-hydroxybenzimidate, by a modification (25) of the procedure of Wood et al. (26) . The specific activity of these preparations averaged 4000 cpm/25 ng of actin. In other experiments, G-actins were labeled via lactoperoxidase (27) .
Coprecipitation and Radioimmunoassay. Procedures for indirect radioimmunoassay for actin were similar to those used for brain tubulin (28) . Briefly, a standard inhibition curve (29) was generated by competition between increasing amounts of unlabeled actin and a constant amount of 125I-actin for a constant, limited number of antibody-binding sites. Each sample, containing 50 ,l of borate-buffered saline (16 mM borate/159 mM NaCl, pH 8.0) with rabbit serum albumin (5 mg/ml), 10 ,l of unlabeled actin, and 10,g1 of antiactin antiserum was incubated for 4 hr at 370C to allow unlabeled actin to bind to the antiserum. Then 10 ,l of '25I-actin was added and the incubation was continued at 370C for 4 hr more. Next, sufficient goat antiserum against rabbit IgG was added to precipitate all rabbit IgG and the sample was processed as described for the coprecipitation tests. The maximum or control amount of labeled actin bound by the antiserum is the amount bound in the absence of unlabeled actin. All determinations were done in triplicate, and the data in the inhibition curves are expressed as the percentage of the uninhibited control specifically precipitated compared to the amount of unlabeled actin in each sample. Uninhibited control precipitation was routinely 40-50% in these studies, as recommended for radioimmunoassays in general (29) , with the amounts of 125I-antigen and antiserum used determined by coprecipitation curves.
Protein Determination and Electrophoresis. Protein concentrations were determined by the method of Lowry et al. (30) . NaDodSO4/polyacrylamide gel electrophoresis was by the method of Shapiro et al. (31) with 7.5% gels (0.1% NaDodSO4), and the gels were stained with Coomassie blue.
RESULTS
Actin Purity and Antigenicity. The various muscle and cytoplasmic actins used in this study were all purified by methods that included cycles of polymerization. They were at least 98-99% pure, as determined by NaDodSO4/polyacrylamide gel electrophoresis. Fig. 1 shows stained gels of preparations of bovine cardiac actin and chicken embryo brain actin used as immunogen and as test antigen, illustrating the purity of the preparations. Any individual contaminant(s) would complexes, nonprecipitating as well as precipitating ones. Fig.  2 shows that the antisera raised against cardiac actin and brain actin specifically bound 64% and 50% of homologous 125I-antigen, respectively, demonstrating the presence of antiactin antibodies. Todination renders variable portions of a protein preparation incapable of interacting with antibody. Thus, the percentage of l25I-actin bound by the antiserum is a reflection of the amount of labeled protein that retains antigenicity and not an indication of impurities in the actin preparation. Furthermore, as shown in Fig. 3 The cardiac actin radioimmunoassay was used to assess the respective abilities of G-actin and F-actin to generate standard inhibition curves. Bovine cardiac actin was purified through two cycles of polymerization-depolymerization. The final Gactin preparation was divided, and one portion was assembled into F-actin in 50 mM KC1. Then, inhibition curves were generated by using unlabeled F-actin or unlabeled G-actin. The curves, shown in Fig. 3 Fig. 2 . Antisera against both chicken embryo brain actin and bovine cardiac actin bound their homologous labeled antigens best. However, all labeled actins bound to the anti-chicken embryo brain actin antisera, demonstrating a high degree of immunological crossreactivity. Although differences in the extent of binding suggest differences between these crossreactive actins, the variable effects of iodination on four different actin preparations make such a conclusion premature. Such a conclusion is warranted by radioimmunoassay comparisons, where unlabeled preparations are competing against a single 125I-actin preparation (see below). In contrast, the antiserum generated against bovine cardiac actin failed to bind either chicken embryo or bovine brain 125I-actin to any significant degree. This result suggests that this antiserum (rabbit 148) may be specific for striated muscle actins because it can still bind labeled rabbit skeletal muscle actin in addition to bovine cardiac actin.
To further explore the immunological relationships between these actins, we generated inhibition curves by using (i) There were, however, demonstrable differences in the efficiency of competition of the various unlabeled actins. Thus, the most effective inhibitor actin was that from chicken embryo brain, followed, in order, by those from bovine brain, bovine cardiac muscle, and rabbit skeletal muscle. These quantitative differences between the various actins can be best explained by different densities of (or subtle structural differences in) the shared antigenic determinants (or both).
The results obtained with antiserum against bovine cardiac actin were different, however. Fig. 4 shows that the binding of cardiac 125I-actin to homologous antiserum was inhibited by unlabeled cardiac actin and skeletal actin, but not by unlabeled chicken embryo brain actin. The difference between bovine cardiac actin and chicken embryo brain actin in this test appears not to be species specific; Fig. 5 demonstrates that bovine brain actin also failed to inhibit binding. Thus, cardiac actin appears to possess a class of antigenic determinants that are not shared with brain actins. This class of determinants is present in skeletal AA. muscle actin; unlabeled rabbit skeletal actin inhibited the binding of cardiac l25sIactin, as shown in Fig. 4. Fig. 6 shows another analysis, with a different preparation of cardiac 125I-actin, fresh preparations of unlabeled actins, and the same antiserum, that confirms the results and demonstrates complete inhibition by skeletal actin. Although skeletal muscle actin inhibited binding, it was less efficient than unlabeled cardiac actin by about 100-fold in both tests. This observation implies differences in shared determinant densities or some structural differences in determinants common to cardiac and skeletal actins, but absent from brain actins.
DISCUSSION
The experiments reported in this paper demonstrate the usefulness and limitations of using antibodies against actin to quantitate actin by radioimmunoassay. In addition, these quantitative immunological techniques resolve antigenic differences between various actins, implying that the small sequence differences that have been found are expressed in antigenic determinant differences in the native molecules. (19) (20) (21) . It may be that we are discriminating between the a-actin that characterizes striated muscles and the 3-and 'y-actins found in cytoplasmic systems (16) (17) (18) 
